Berkeley Lights to Report First Quarter 2022 Financial Results on May 9, 2022
Berkeley Lights, Inc. (Nasdaq: BLI) is set to report its first quarter 2022 financial results on May 9, 2022, after market close. A conference call will follow at 1:30 p.m. PT/4:30 p.m. ET. The event will be webcast live, with access on the Company’s website and archived for later viewing. Berkeley Lights specializes in digital cell biology, creating platforms for the rapid development of biotherapeutics and cell-based products, providing an integrated solution for cell characterization.
- Upcoming financial results may provide insights into business performance and potential growth.
- Company's digital cell biology platform is advancing biotherapeutics development, potentially attracting more customers.
- The forward-looking statements carry substantial risks and uncertainties, indicating potential volatility.
EMERYVILLE, Calif., April 26, 2022 (GLOBE NEWSWIRE) -- Berkeley Lights, Inc. (Nasdaq: BLI), a leader in digital cell biology, today announced that the Company will be reporting financial results for the first quarter 2022 after market on Monday, May 9, 2022. Company management will be webcasting a corresponding conference call beginning at 1:30 p.m. Pacific Time / 4:30 p.m. Eastern Time.
Live audio of the webcast will be available on the “Investors” section of the Company’s website at www.berkeleylights.com. The webcast will be archived and available for replay after the event.
About Berkeley Lights
Berkeley Lights is a leading digital cell biology company focused on enabling and accelerating the rapid development and commercialization of biotherapeutics and other cell-based products for our customers. The Berkeley Lights Platform captures deep phenotypic, functional, and genotypic information for thousands of single cells in parallel and can also deliver the live biology customers desire in the form of the best cells. Our platform is a fully integrated, end-to-end solution, comprising proprietary consumables, including our OptoSelect™ chips and reagent kits, advanced automation systems, and application software. We developed the Berkeley Lights Platform to provide the most advanced environment for rapid functional characterization of single cells at scale, the goal of which is to establish an industry standard for our customers throughout their cell-based product value chain.
Forward-Looking Statements
To the extent that statements contained in this press release are not descriptions of historical facts regarding Berkeley Lights or its products, they are forward-looking statements reflecting the current beliefs and expectations of management. Such forward-looking statements involve substantial known and unknown risks and uncertainties that relate to future events, and actual results and product performance could differ significantly from those expressed or implied by the forward-looking statements. Berkeley Lights undertakes no obligation to update or revise any forward-looking statements. For a further description of the risks and uncertainties relating to the Company’s growth and continual evolution see the statements in the "Risk Factors" sections, and elsewhere, in our filings with the U.S. Securities and Exchange Commission.
Media Contact
Media@berkeleylights.com
Investor Contact
IR@berkeleylights.com
FAQ
When will Berkeley Lights report its Q1 2022 financial results?
What time is the Berkeley Lights conference call?
How can I access the Berkeley Lights earnings call?
What is the focus of Berkeley Lights as a company?
What risks does Berkeley Lights mention in their press release?
